 Catherine Demers
Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| White Matter | 3 | 2024 | 135 | 1.640 |
Why?
| | Mothers | 2 | 2024 | 731 | 0.620 |
Why?
| | Amygdala | 3 | 2022 | 192 | 0.520 |
Why?
| | Arachidonic Acids | 1 | 2016 | 59 | 0.490 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2016 | 61 | 0.480 |
Why?
| | Endocannabinoids | 1 | 2016 | 53 | 0.480 |
Why?
| | Anxiety | 2 | 2024 | 976 | 0.440 |
Why?
| | Hair | 2 | 2024 | 73 | 0.430 |
Why?
| | Diffusion Tensor Imaging | 2 | 2024 | 76 | 0.400 |
Why?
| | Home Care Services | 1 | 2015 | 244 | 0.380 |
Why?
| | Hydrocortisone | 2 | 2024 | 306 | 0.380 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2016 | 2062 | 0.360 |
Why?
| | Heart Failure | 3 | 2024 | 2148 | 0.320 |
Why?
| | Brain | 5 | 2024 | 2677 | 0.280 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2024 | 573 | 0.280 |
Why?
| | Longitudinal Studies | 3 | 2024 | 2724 | 0.280 |
Why?
| | Magnetic Resonance Imaging | 7 | 2024 | 3397 | 0.270 |
Why?
| | Pregnancy | 10 | 2024 | 6423 | 0.240 |
Why?
| | Anisotropy | 1 | 2024 | 73 | 0.230 |
Why?
| | Limbic System | 1 | 2024 | 47 | 0.220 |
Why?
| | Gestational Age | 2 | 2024 | 876 | 0.220 |
Why?
| | Psychotherapy, Brief | 1 | 2023 | 32 | 0.200 |
Why?
| | Signal Transduction | 1 | 2016 | 4935 | 0.190 |
Why?
| | Sleep | 2 | 2024 | 689 | 0.180 |
Why?
| | Female | 22 | 2024 | 68829 | 0.180 |
Why?
| | Infant | 3 | 2024 | 9018 | 0.180 |
Why?
| | Birth Weight | 1 | 2024 | 505 | 0.180 |
Why?
| | Stroke Volume | 1 | 2024 | 593 | 0.180 |
Why?
| | Social Behavior | 2 | 2013 | 286 | 0.170 |
Why?
| | Prospective Studies | 5 | 2023 | 7158 | 0.160 |
Why?
| | Child Development | 1 | 2024 | 459 | 0.160 |
Why?
| | Depressive Disorder, Major | 1 | 2023 | 345 | 0.160 |
Why?
| | Racism | 1 | 2021 | 128 | 0.160 |
Why?
| | Emotions | 1 | 2024 | 545 | 0.160 |
Why?
| | Psychoses, Substance-Induced | 1 | 2019 | 14 | 0.150 |
Why?
| | Premature Birth | 1 | 2022 | 317 | 0.150 |
Why?
| | Gray Matter | 1 | 2019 | 81 | 0.150 |
Why?
| | Stress, Psychological | 3 | 2017 | 1070 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 2 | 2019 | 2271 | 0.150 |
Why?
| | Sex Characteristics | 2 | 2013 | 735 | 0.150 |
Why?
| | Humans | 22 | 2024 | 129847 | 0.140 |
Why?
| | Male | 17 | 2024 | 63759 | 0.130 |
Why?
| | Adult | 12 | 2024 | 35634 | 0.130 |
Why?
| | Infant, Newborn | 7 | 2024 | 5772 | 0.130 |
Why?
| | Frontal Lobe | 1 | 2017 | 154 | 0.130 |
Why?
| | Polyunsaturated Alkamides | 1 | 2016 | 6 | 0.130 |
Why?
| | Depression | 3 | 2023 | 1323 | 0.130 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2016 | 27 | 0.120 |
Why?
| | Amidohydrolases | 1 | 2016 | 30 | 0.120 |
Why?
| | Marijuana Abuse | 1 | 2019 | 233 | 0.120 |
Why?
| | Genome-Wide Association Study | 2 | 2019 | 1326 | 0.120 |
Why?
| | Perception | 1 | 2017 | 347 | 0.110 |
Why?
| | Receptors, AMPA | 1 | 2015 | 137 | 0.110 |
Why?
| | Pregnancy Trimester, Third | 2 | 2024 | 109 | 0.110 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2016 | 534 | 0.110 |
Why?
| | Touch | 1 | 2013 | 37 | 0.100 |
Why?
| | Impulsive Behavior | 1 | 2013 | 127 | 0.100 |
Why?
| | Maternal Behavior | 1 | 2013 | 74 | 0.100 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 569 | 0.100 |
Why?
| | Cocaine-Related Disorders | 1 | 2013 | 108 | 0.100 |
Why?
| | Self Concept | 1 | 2013 | 240 | 0.090 |
Why?
| | Pregnancy Complications | 2 | 2024 | 494 | 0.090 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 739 | 0.090 |
Why?
| | Oxygen | 1 | 2016 | 916 | 0.090 |
Why?
| | Genotype | 1 | 2016 | 1829 | 0.090 |
Why?
| | Self Care | 1 | 2013 | 368 | 0.080 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 1368 | 0.080 |
Why?
| | Behavior, Animal | 1 | 2013 | 496 | 0.080 |
Why?
| | Chronic Disease | 1 | 2015 | 1724 | 0.080 |
Why?
| | Dalteparin | 1 | 2008 | 10 | 0.080 |
Why?
| | Cognitive Dysfunction | 1 | 2013 | 347 | 0.070 |
Why?
| | Opioid-Related Disorders | 1 | 2015 | 484 | 0.070 |
Why?
| | Pregnancy Outcome | 3 | 2024 | 392 | 0.070 |
Why?
| | Siblings | 2 | 2019 | 216 | 0.070 |
Why?
| | Cardiologists | 1 | 2024 | 46 | 0.050 |
Why?
| | Young Adult | 2 | 2016 | 12467 | 0.050 |
Why?
| | Placenta | 1 | 2008 | 716 | 0.050 |
Why?
| | Telomere Shortening | 1 | 2022 | 20 | 0.050 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2024 | 385 | 0.040 |
Why?
| | Telomere | 1 | 2022 | 232 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2024 | 542 | 0.040 |
Why?
| | Neuropsychological Tests | 2 | 2013 | 1016 | 0.040 |
Why?
| | Interview, Psychological | 1 | 2019 | 93 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2016 | 14553 | 0.040 |
Why?
| | Sex Factors | 1 | 2024 | 1973 | 0.040 |
Why?
| | Calcitriol | 2 | 1995 | 54 | 0.040 |
Why?
| | Cholecalciferol | 2 | 1995 | 56 | 0.040 |
Why?
| | Diseases in Twins | 1 | 2019 | 175 | 0.040 |
Why?
| | Hippocampus | 1 | 2022 | 844 | 0.030 |
Why?
| | Middle Aged | 4 | 2024 | 31177 | 0.030 |
Why?
| | Clinical Competence | 1 | 2024 | 1020 | 0.030 |
Why?
| | Thrombocythemia, Essential | 1 | 1996 | 7 | 0.030 |
Why?
| | Pregnancy Complications, Hematologic | 1 | 1996 | 20 | 0.030 |
Why?
| | Steroid Hydroxylases | 1 | 1995 | 22 | 0.030 |
Why?
| | Prognosis | 1 | 2024 | 3773 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2019 | 5085 | 0.030 |
Why?
| | Habituation, Psychophysiologic | 1 | 2015 | 53 | 0.030 |
Why?
| | Vitamin D Deficiency | 2 | 1995 | 177 | 0.030 |
Why?
| | Interferon-alpha | 1 | 1996 | 194 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2015 | 408 | 0.030 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1995 | 151 | 0.030 |
Why?
| | Risk Assessment | 1 | 2024 | 3269 | 0.030 |
Why?
| | Intestine, Small | 1 | 1995 | 151 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1995 | 284 | 0.030 |
Why?
| | Species Specificity | 1 | 2015 | 568 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 3 | 2013 | 2403 | 0.030 |
Why?
| | Judgment | 1 | 2013 | 60 | 0.030 |
Why?
| | Hypocalcemia | 1 | 1993 | 27 | 0.030 |
Why?
| | Receptors, Dopamine | 1 | 2013 | 16 | 0.030 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2013 | 71 | 0.030 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2013 | 20 | 0.030 |
Why?
| | Video Recording | 1 | 2013 | 164 | 0.030 |
Why?
| | Alcohol Drinking | 1 | 2019 | 764 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2013 | 173 | 0.020 |
Why?
| | Communication Barriers | 1 | 2013 | 98 | 0.020 |
Why?
| | Corpus Striatum | 1 | 2013 | 154 | 0.020 |
Why?
| | Calcium | 2 | 1995 | 1212 | 0.020 |
Why?
| | RNA, Messenger | 3 | 2013 | 2703 | 0.020 |
Why?
| | Registries | 1 | 2019 | 1903 | 0.020 |
Why?
| | Child | 2 | 2022 | 20962 | 0.020 |
Why?
| | Rats | 3 | 2013 | 5487 | 0.020 |
Why?
| | Aged | 2 | 2024 | 22107 | 0.020 |
Why?
| | Recurrence | 1 | 2013 | 1013 | 0.020 |
Why?
| | Residence Characteristics | 1 | 2013 | 332 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2013 | 439 | 0.020 |
Why?
| | Brain Mapping | 1 | 2013 | 575 | 0.020 |
Why?
| | ErbB Receptors | 1 | 1993 | 605 | 0.020 |
Why?
| | Executive Function | 1 | 2013 | 433 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2023 | 10241 | 0.020 |
Why?
| | Fetal Death | 1 | 2008 | 55 | 0.020 |
Why?
| | Patient Care Team | 1 | 2013 | 603 | 0.020 |
Why?
| | Infant, Low Birth Weight | 1 | 2008 | 134 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2008 | 220 | 0.020 |
Why?
| | Pre-Eclampsia | 1 | 2008 | 187 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2013 | 3384 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 3161 | 0.020 |
Why?
| | Cognition | 1 | 2013 | 1125 | 0.020 |
Why?
| | Animals | 4 | 2015 | 35409 | 0.020 |
Why?
| | Mass Screening | 1 | 2013 | 1192 | 0.010 |
Why?
| | Liver | 1 | 1993 | 1839 | 0.010 |
Why?
| | Risk Factors | 1 | 2019 | 9801 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2545 | 0.010 |
Why?
| | Pilot Projects | 1 | 2008 | 1597 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7066 | 0.010 |
Why?
| | Adolescent | 1 | 2019 | 20451 | 0.010 |
Why?
| | Vitamin D3 24-Hydroxylase | 1 | 1995 | 15 | 0.010 |
Why?
| | DNA Probes | 1 | 1995 | 60 | 0.010 |
Why?
| | Enzyme Induction | 1 | 1995 | 90 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1995 | 196 | 0.010 |
Why?
| | Transforming Growth Factor alpha | 1 | 1993 | 57 | 0.010 |
Why?
| | Down-Regulation | 1 | 1995 | 631 | 0.010 |
Why?
| | Aspirin | 1 | 1996 | 380 | 0.010 |
Why?
| | Epidermal Growth Factor | 1 | 1993 | 170 | 0.010 |
Why?
| | Analysis of Variance | 1 | 1995 | 1291 | 0.010 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 1996 | 443 | 0.010 |
Why?
| | Phosphorylation | 1 | 1993 | 1716 | 0.000 |
Why?
|
|
Demers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|